synthesis of squaramic acids from a dissymmetric diester (3-tert-butoxy-4-ethoxycyclobut-3-en-1,2-dione). This efficient procedure avoids the synthesis of the undesired squaramides. Secondly we describe a microplate parallel synthesis (15µmol-scale) of squaric acid hydroxamate amides from a squaric hydroxamate ester.
Abstract: Many natural privileged scaffolds contain a basic nitrogen atom, which often is a key element of pharmacophore and a chemically reactive centre as well. In our ongoing research program devoted to the design of targeted libraries based on acidic templates, we develop methods to convert privileged basic compounds -like natural alkaloids or drugs-into acidic compounds. This conversion leads to a profound alteration of the pharmacophore, without changing the overall shape and lipophilicity of the molecule. We expect such modifications to generate unexpected biological activities. Recently, we focused on derivatives of squaric acid, a vinylogous carboxylic acid. Two series were studied. First we describe a new, selective parallel Introduction Privileged structures.
The construction of a library of "biologically" competent compounds is a cornerstone of HTS-based lead discovery. Recognition of frequently active templates (natural or synthetic) and published data on side-effects of known drugs provides guidelines for the selection of compounds. [1] In 1988, Evans introduced the concept of "privileged structure" to account for the outstanding recurrence of some scaffolds, such as benzodiazepines, in the world of bioactive compounds. Since then, numerous teams have focused on their use in medicinal chemistry. [2] [3] [4] [5] More recently, IUPAC has given a structural definition that corresponds to the common denominator of Evans' privileged structures. [3] According to that definition a privileged structure is substructure "that often consists of a semi-rigid scaffold, which is able to present multiple hydrophobic residues without undergoing hydrophobic collapse". [4] This definition is useful for the construction of screening library because it offers selection criterias independent of any established biological activity. We ourselves have developed series of bio-inspired privileged structures: "spiro-compounds" and tropane-based compounds. [5] [6] Among privileged structures that are also found in natural compounds, piperidine and piperazine in one hand, and phenethylamine, tryptamine, histamine derivatives (cyclized or not) in the other hand, are interesting because they contain a basic nitrogen atom i . [7] 
Drug-morphing and combinatorial synthesis of privileged structures
We have been interested into drug-morphing, i.e. transforming biologically active compounds on a target to related compounds active on new targets, by changes in pharmacophore. Wermuth and coll. have applied this concept to commercially available drugs and name it the "SOSA-Approach". [8] We intend to modify the amine function of privileged compounds into new pharmacophores by simple chemical reactions. Recently, we focused on squaric acid as a key chemical intermediate that could serve the design of chemical libraries for screening. We use privileged bioinspired amines and transform them into squaric acid derivatives. In particular, we i For examples, see catalogs of building-blocks providers like ChemFiles from Sigma-Aldrich.Inc or Optimer-Building Blocks from Array biopharma. aimed at addressing two key problems encountered in medicinal chemistry ( Figure   1 ). First, these compounds can palliate the shortage of acidic compounds in screening libraries. Indeed, squaramic acid and squaric acid N-hydroxylamide amide derivatives are monobasic acid with pKa of 2-3 [9] and 8-9 ii respectively. Secondly, these compounds display new chelating zing-binding groups (ZBGs) that are highly desirable in medicinal chemistry. 
. Squaric acid in medicinal chemistry
Squaric acid is a diacid that exhibits two acidic hydroxyl groups with pKa values of 0.54 and 3.48 as well as two highly polarized carbonyl groups. [10] This unique structure provides not only versatile proton acceptor sites [11] at the carbonyl function for hydrogen bonding but also binding sites to metal ions. [12, 13] Since the pioneering work of Cohen [14] in 1959, many examples of the use of squaric template ( Figure 2 
Converting basic compounds to acidic compounds

Evidencing the lack of acidic structures in screening libraries.
Among We have been interested in the past few years in synthesizing acidic privileged structures. We focused on acidic heterocycles and hydroxamic acids, in order to supply our in-house collection with acidic compounds. [26] [27] We now focus on squaric acid derivatives and are interested in incorporating squaric moiety in small lead-or drug-like molecules using a simple chemical group transformation for the conversion of rather common secondary or primary amines into a less common acidic group. Piperidines were successfully converted into squaric amides (Table 1, 2a-2e) .
A simple procedure to convert drug-like amines into acidic compounds a-Parallel synthesis
The reaction was selective and amide functionalities did not react with the squaric ester (compounds 2a-2b) .
Trifluoro-methyl derivatives afforded squaramic acid with good to excellent yields (compounds 2c-2d) and the presence of a potentially reactive alcohol was well tolerated (compound 2e).
Efficient reaction also occurred with piperazines diversely substituted in position 4 (Table 1, 2f-2h) .
Diphenylmethyl piperazine was successfully converted into squaramic acid 2f.
N-(2-nitro-4-trifluoromethylphenyl) piperazine was also an excellent substrate (compound 2g).
The reaction of norfloxacin proceeded with good yield (compound 2h) and resulted in a complete change of the pharmacophore of this potent antibiotic. The same observation was made on the antidepressant maprotiline, that was converted with good yield into the corresponding squaramic acid (compound 2i).
The squaric derivative of 2,4-dimethoxy-N-methylphenethylamine (compound 2j) was obtained with a medium yield of 63%, since the protected intermediate was an oil that proved to be difficult to handle. The lower yields (below 80%) obtained for some compounds (2a; 2e; 2g; 2h)
were due to the more difficult substitution of squaric ester by the amine that eventually required to heat the reaction mixture and/or to add more equivalents of triethylamine. Tert-butyle deprotection was in all cases quantitative. The scope of this efficient procedure for preparation of squaramic acids was extended to the synthesis of some squaric peptidomimetic derivatives isolated with excellent yields (Table2). 
Converting basic compounds to zinc chelating compounds
Evidencing the need for new Zinc-Binding Groups (ZBG)
Since long, Zn metallohydrolases have interested the medicinal chemistry community. They are important biological targets for drugs on the market or in clinical trials, such as inhibitors of angiotensin-converting enzyme carbonic anhydrase or more recently Histone Desacetylase [33-34-35] (Figure 7) .
When targeting metalloproteases, a ZBG is necessary to bind to the Zinc ion ( Figure   8 ) and sets the rest of the molecule in the active site. Using hydroxamate is convenient to achieve good activity at the screening stage because this function is one of the best Zn ligand. Nevertheless, a high binding to the target can be achieved with a "softer" ZBG, provided that the rest of the molecule fits nicely in the binding pocket ( Figure 8 ). [36] Furthermore, because hydroxamic acids are often poorly absorbed and are prone to metabolic degradation and glucuronidation, there has been considerable interest in discovering alternative groups that can be incorporated in the structures of metalloproteases inhibitors.
[37] The search of relevant new zing binding groups is widely investigated. ZBG can be classified in two classes as shown in Figure 9 
Selection of squaric Acid N-hydroxylamines template as Zn-chelating moiety.
Brucker and co-workers have demonstrated that vinylogous hydroxamic acids derived from squaric acids are good metal chelators ( Figure 10 ) and squaric acidbased inhibitors of matrix metalloproteases were reported. [15a,42] Hanessian et al.
also replaced the hydroxamic acid of SAHA by squaric acid and squaric hydroxamic acid. [17] In both cases (HDAC or MMP inhibitors) no inhibitory activity was observed below 1.0 µM and it was not clear wether the spatial requirements could be satisfied in the active sites of these enzymes. viii The squaric/hydroxamic acid hybrids are generally not as potent as hydroxamic acid-based inhibitors, many of which have inhibition constants in the nM range but these hybrids nevertheless deserve viii Analogues of SAHA bearing either a squaric acid N-hydroxylamine or thio squaric derivatives or methylthioesters derivatives did not display activity below 1µM. screening to generate an alternative starting point for the design of inhibitors with perhaps improved pharmacological properties.
Nevertheless, very few squaric acid N-hydroxylamines amides have been prepared and described until now. [43] a-Parallel synthesis 
b-Choice of amines
Amines were chosen in order to generate a diversity of pharmacophore properties and geometries. Primary and secondary amines were selected. Among the primary ix Charton, J., Deprez-Poulain, R., Deprez, B. Tetrahedron Lett. submitted amines (54 inputs, Figure 11 ), aliphatic amines, aromatic amines (benzylamines, phenethylamines, anilines…), amino-alcohol and amino-acids were incorporated.
Among secondary amines (20 inputs, Figure 11 ), cyclic amines (piperidines, piperazines) and acyclic secondary amines were selected. As explained above, such building-blocks are expected to behave as privileged structures. 
Discussion-Conclusion
Recent attention has focused on the need to assess the potential for bioavailability problems of potential drug candidates early in the drug discovery cycle. Lipophilicity, hydrophilicity, hydrogen bonding and pKa are likely to be important factor for absorption, transport and excretion of compounds. [44] We compared the initial physico-chemical profile of amines with the final squaric acid derivatives either squaramic acids or squaric acid hydroxamate amides ( Figure 12 ). x Interestingly, these compounds differ mainly from amines by pKa and charge at physiological pH, and the presence of a potentially ZBG.
Using conventional Zn ligands and this original array of squaramides and squaramic acids we have recently started an in vitro screening campaign on six Zn x For ease of discussion, average values were attributed to initial amine buiding-blocks. metalloproteases. Inhibitors will be used for the functional exploration of these enzymes in several biological setups. 
